Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. (Q54786912)

3 June 2018

title

Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. (English)

1 reference

3 June 2018

1 reference

Hidetaka Yamamoto

1

1 reference

3 June 2018

Taro Tobo

2

1 reference

3 June 2018

Mari Nakamori

3

1 reference

3 June 2018

Masakazu Imamura

4

1 reference

3 June 2018

Aya Kojima

5

1 reference

3 June 2018

Yoshinao Oda

6

1 reference

3 June 2018

Norimoto Nakamura

7

1 reference

3 June 2018

Tomonari Takahira

8

1 reference

3 June 2018

Takashi Yao

9

1 reference

3 June 2018

Masazumi Tsuneyoshi

10

1 reference

3 June 2018

publication date

20 November 2008

1 reference

3 June 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

3 June 2018

volume

135

1 reference

3 June 2018

issue

6

1 reference

3 June 2018

page(s)

791-798

1 reference

3 June 2018

Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0514-Z

Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0514-Z

Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).

21 January 2018

1 reference

12 December 2020

Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors)

1 reference

12 December 2020

Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours

1 reference

12 December 2020

NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics.

1 reference

12 December 2020

Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo

1 reference

12 December 2020

Somatic mutations in the neurofibromatosis 1 gene in human tumors

1 reference

12 December 2020

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

12 December 2020

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate

1 reference

12 December 2020

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

12 December 2020

DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance

1 reference

12 December 2020

Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.

1 reference

12 December 2020

Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer

1 reference

12 December 2020

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors

1 reference

12 December 2020

Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.

1 reference

12 December 2020

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study

1 reference

12 December 2020

Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases

1 reference

12 December 2020

PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor

1 reference

12 December 2020

Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients

1 reference

12 December 2020

Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease)

1 reference

12 December 2020

Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

1 reference

12 December 2020

1 reference

12 December 2020

The neurofibromatosis type 1 gene encodes a protein related to GAP

1 reference

12 December 2020

KIT activation is a ubiquitous feature of gastrointestinal stromal tumors

1 reference

12 December 2020

Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors

1 reference

12 December 2020

Regulation of the Ras signalling network

1 reference

12 December 2020

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

1 reference

12 December 2020

c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue).

1 reference

12 December 2020

Familial gastrointestinal stromal tumours with germline mutation of the KIT gene

1 reference

12 December 2020

Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours

1 reference

12 December 2020

Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1

1 reference

12 December 2020

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

1 reference

12 December 2020

10.1007/S00432-008-0514-Z

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018